Latest Breaking News On - Antos da silva jorge - Page 1 : comparemela.com

Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (NASDAQ:MLTX), has sold 60,000 shares of the company on February 20, 2024, according to a recent SEC Filing.

Moonlake immunotherapeuticsBiopharmaceutical companyNsider transactionNsider transactionsAntos da silva jorgeInsider activityInflammatory diseases